Biogen to build blood disorder drug franchise | Reuters
Links shared publicly online about this topic.
- 463total visits
Biogen to build blood disorder drug franchise | Reuters
View full resource at reuters.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Disease and Condition, Drug, Tysabri, Biogen Idec
Most Recently Shared on March 4, 2011 at 5:27 pm By:
Biogen to build blood disorder drug franchise http://ow.ly/1bCaQn
Biogen to build blood disorder drug franchise | Reuters
reuters.com — “BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.The” View full resource at reuters.com
Most Recently Shared on March 4, 2011 at 4:58 pm By:
Biogen to build blood disorder drug franchise http://is.gd/JG4sYs
Biogen to build blood disorder drug franchise
health.yahoo.net — “Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.” View full resource at health.yahoo.net
Most Recently Shared on March 4, 2011 at 4:56 pm By:
Correction: Biogen to build blood disorder drug franchise http://bit.ly/gSPmx1
Biogen to build blood disorder drug franchise | Reuters
reuters.com — “BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.The” View full resource at reuters.com
Most Recently Shared on March 4, 2011 at 4:55 pm By:
Biogen to build blood disorder drug franchise http://bit.ly/hC5Sjp
Advertisement

